Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
03/2004
03/04/2004WO2004017961A2 Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (gnrh) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer
03/04/2004WO2004017911A2 Protease inhibitors
03/04/2004WO2004017908A2 Calcium receptor modulating compound and use thereof
03/04/2004WO2003088917A3 Regulation of tnf-alpha
03/04/2004WO2003060082A3 Use of modified pyrimidine compounds to promote stem cell migration and proliferation
03/04/2004WO2003059276A3 Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof
03/04/2004WO2003049527A3 Mitotic kinesin inhibitors
03/04/2004US20040044210 Miniaturization; network of hydrogen bonding
03/04/2004US20040044199 Cyclic urea compounds and preparation thereof
03/04/2004US20040044198 Reacting chlorin with base; heating, acidification; used for photodynamic therapy
03/04/2004US20040044062 Method of treatment of viral infection including HIV using water soluble fullerenes - III
03/04/2004US20040044014 Controlling signal transduction; tyrosine kinase inhibitors; benign prostatic hyperplasmia; respiratory system disorders; antitumor agents
03/04/2004US20040044012 Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation
03/04/2004US20040044010 Central nervous system disorders; Alzheimer's disease; Parkinson's disease
03/04/2004US20040043998 Preventive or therapeutic medicines for diabetes containing fused-heterocyclic compounds or their salts
03/04/2004US20040043991 Antiarthritic agents; anticancer agents; antiinflammatory agents
03/04/2004US20040043982 Alzheimer's disease
03/04/2004US20040043965 Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents
03/04/2004US20040043388 Compositions and methods for isolating ligand binding polypeptides for a user-specified ligand, and for isolating small molecule ligands for a user-specified target polypeptide using an improved class of hybrid ligand compounds
03/04/2004US20040043247 Organic electroluminescence devices using pyrazolo [3,4B] quinoxaline derivatives
03/04/2004US20040043001 Pharmaceutical formulations of antineoplastic agents and processes of making and using the same
03/04/2004DE10239042A1 New fused macrocyclic pyrimidine derivatives, useful as e.g. cyclin-dependent kinase inhibitors for treating e.g. cancer, autoimmune, cardiovascular or neurodegenerative diseases or viral infections
03/04/2004DE10238724A1 New 6-alkyl-1,5-dihydro-4H-pyrazolo-(3,4-d)-pyrimidin-4-ones useful as selective phosphodiesterase 9A inhibitors for improving attention, concentration, learning and/or memory performance
03/04/2004CA2496479A1 Process for producing indolopyrrolocarbazole derivative
03/04/2004CA2496303A1 Methods for regulating transcription by targeting quadruplex dna
03/04/2004CA2496246A1 Pyrrole based inhibitors of glycogen synthase kinase 3
03/04/2004CA2495484A1 Liquid crystal display and colour filter with improved transparency for green light
03/04/2004CA2494263A1 Microbiocidal (e.g. fungicidal) 1,2,3-triazole derivatives
03/04/2004CA2494127A1 Pyrimido compounds having antiproliferative activity
03/03/2004EP1394870A2 Organic light emitting device
03/03/2004EP1394243A1 Cyclic aminothioureas as additives for lubricating oils
03/03/2004EP1394240A1 Bicyclic thioamides as additives for lubricating oils
03/03/2004EP1394238A1 Cyclic nitroxyl compounds as additives for lubricating oils
03/03/2004EP1394152A1 2-iminoimidazole derivatives (1)
03/03/2004EP1393747A1 Preventives/remedies for alzheimer's disease
03/03/2004EP1392695A2 Triazolopyrimidines
03/03/2004EP1392694A1 Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine and the use thereof for the preparation of pyrrolo[2,3]pyrimidine derivatives as protein kinases inhibitors
03/03/2004EP1392693A1 Triazolopyrimidines
03/03/2004EP1392692A1 (oxo-pyrazolo 1,5a]pyrimidin-2-yl)alkyl-carboxamides
03/03/2004EP1392691A1 ANTIFUNGAL 4-SUBSTITUTED 5,6-DIHYDRO-4 u H /u -PYRROLO 1,2-A] 1,4]BENZODIAZEPINES
03/03/2004EP1392689A1 Tri- and tetraaza-acenaphthylen derivatives as crf receptor antagonists
03/03/2004EP1392688A1 Pyrazino[1',2':1,6]pyrido[3,4-b]indole1,4-dione derivatives
03/03/2004EP1392684A1 Thiazole compounds useful as inhibitors of protein kinases
03/03/2004EP1392664A1 Epothilone derivatives
03/03/2004EP1392328A2 Cancer therapy
03/03/2004EP1392314A1 Novel use of 2-phenyl-substituted imidazotriazinones
03/03/2004EP1392312A1 TRIAZOLO 4,5-d] PYRIMIDINE DERIVATIVES AND THEIR USE AS PURINERGIC RECEPTOR ANTAGONISTS
03/03/2004EP1392307A1 Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene
03/03/2004EP1392292A2 Pyranoindazoles and their use for the treatment of glaucoma
03/03/2004EP1392264A1 Delivery of antiemetics through an inhalation route
03/03/2004EP1392262A1 Delivery of drug esters through an inhalation route
03/03/2004EP1392261A2 Delivery of nonsteroidal antiinflammatory drugs through an inhalation route
03/03/2004EP1392259A2 Delivery of erectile dysfunction drugs through an inhalation route
03/03/2004EP1392257A1 Delivery of antihistamines through an inhalation route
03/03/2004EP1307460B1 METHOD FOR THE PRODUCTION OF IMIDAZO-[1,2-c][2,3]-BENZODIAZEPINES AND INTERMEDIATES IN THE PRODUCTION THEREOF
03/03/2004EP1282624B1 Crf receptor antagonists and methods relating thereto
03/03/2004EP1242425B1 N-(5,7-DIMETHOXY[1,2,4]TRIAZOLO[1,5-a]PYRIMIDIN-2-YL) ARYLSULFONAMIDE COMPOUNDS AND THEIR USE AS HERBICIDES
03/03/2004EP1152003B1 Process for production of optically active pyrroloazepine derivatives
03/03/2004EP0986386B1 Use of nitrogen heterocyclic aromatic derivatives in the topical treatment of the epithelial tissues diseases
03/03/2004EP0946527B1 Salting-out process of crystallizing 2,4,6,8,10,12-hexanitro-2,4,6,8,10,12-hexaazatetracyclo 5.5.0.0?5,9 0?3,11 ]-dodecane
03/03/2004CN1479740A Substituted 3,4-dihydro-pyrido [1,2-a] pyrimidines
03/03/2004CN1479619A Use of pyrazolo [4,3-d] pyrimidines
03/03/2004CN1478780A Synthesis method of triethylene diamine from piperazine by product
03/03/2004CN1140528C Process for preparation of herbicidal derivatives
03/03/2004CN1140269C Bicyclic compounds capable of inhibiting tyrosine kinases of epidermal growth factor receptor family
03/02/2004US6699991 Process for the preparation of pyrazoles
03/02/2004US6699871 Such as 7-((3r)-3-amino-4-(3,4-difluorophenyl)butanoyl)-2-(trifluoromethyl)-5,6,7,8 -tetrahydroimidazo(1,2-a)pyrazine dihydrochloride for treatment of insulin resistance disorders
03/02/2004US6699859 Treatment of anxiety and convulsions.
03/02/2004US6699856 Pyrazinones, compositions containing such compounds and methods of use
03/02/2004US6699855 Pyrrolopyrazinones useful as serine protease inhibitors
03/02/2004US6699651 Base precursors for use in a photothermographic element
03/02/2004CA2138289C N-substituted azabicycloheptane derivatives, the preparation and use thereof
02/2004
02/28/2004WO2004092177A1 Triazolopyrazines and methods of making and using the same
02/26/2004WO2004016616A1 Aryl-substituted diazabicycloalkanes as nicotinic acetylcholine agonists.
02/26/2004WO2004016615A1 PYRAZOLO (4,3c) CINNOLINE COMPOUNDS AS INHIBITORS OF ITK KINASE ACTIVITY
02/26/2004WO2004016614A2 Pyrrolopyrazines as kinase inhibitors
02/26/2004WO2004000237A3 Enhancing treatment of mdr cancer with adenosine a3 antagonists
02/26/2004WO2003103575A3 Compounds, compositions, and methods
02/26/2004WO2003060085A3 Mammalian neural stem cells, compositions and uses thereof
02/26/2004WO2003045334A3 Methods and compositions for ameliorating the undesirable effects of chemotherapy
02/26/2004WO2003035553A3 A process for the microbiological decontamination of water by means of photosensitive agents
02/26/2004WO2003027110A3 Process for preparing 2-(4-pyridyl) amino-6-dialkyloxyphenyl-pyrido [2,3-d]pyrimidin-7-ones
02/26/2004WO2003013541A8 4-amino-6-phenyl-pyrrolo[2,3-d]pyrimidine derivatives
02/26/2004WO2002083683A9 Novel tricyclic pyridyl benzazepine carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists
02/26/2004US20040039211 Tetrapyrroles
02/26/2004US20040039200 1,2,3,4,10,10a-hexahydropyrazino(1,2-a)indole derivatives useful for treating disorders of the central nervous system; damage to the central nervous system; cardiovascular disorders; gastrointestinal disorders, and diabetes
02/26/2004US20040039197 Cyclic indole and heteroindole derivatives and methods for making and using as pharmaceuticals
02/26/2004US20040039195 Cucurbituril derivatives, their preparation method and uses
02/26/2004US20040039004 Nitrogen compounds such as 4-(5-amino-7-phenethyl-7H-pyrazolo (4,3-e)(1,2,4)triazolo(1,5-c)pyrimidin-2-yl)-phenol, used as adenosine receptor antagonists, for prophylaxis of nervous, cardiovascular, respiratory, urogenital and immune disorders
02/26/2004US20040039000 6-aminofuro(2,3-d)pyrimidines and 6-aminopyrrolo(2,3-d) pyrimidines useful in treating cancer, and secondary infections caused by Pneumocystis carinii and Toxoplasmosis gondii
02/26/2004US20040038995 Inhibitors of both KDR an FGFR kinases and are selective against LCK; for treatment of solid tumors, in particular breast, colon, lung and prostate tumors.
02/26/2004US20040038994 Pyrimidine fused bicyclic metalloproteinase inhibitors
02/26/2004US20040038993 Pyrazolo[1,5a]pyrimidine compounds as antiviral agents
02/26/2004US20040038983 3-aza- and 1,4-diaza-bicyclo[4.3.0]nonanes, and methods of use thereof
02/26/2004US20040038980 Imidazo-heterobicycles as factor xa inhibitors
02/26/2004US20040038978 Chemical compounds
02/26/2004US20040038971 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
02/26/2004US20040038962 Treatment of nocturnal enuresis, nocturia, polyuria resulting from central diabetes insipidus, urinary incontinence or bleeding disorders such a hemophilia
02/26/2004US20040037022 Aminoalcohol derivatives
02/26/2004DE10316660A1 New diarylacetic acid quaternized azabicycloheptyl esters, useful e.g. for treating asthma, chronic obstructive pulmonary disease, arrhythmia or menstrual disorders, are anticholinergic agents